2 ‘hot’ growth stocks you can’t afford to ignore

Roland Head highlights two out-of-favour growth stocks with the potential to surprise the market.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Making money in the stock market isn’t about being popular, it’s about being right. When an entire sector falls out of favour with the wider market, it’s often worth searching for pockets of value.

In this article I’ll look at two very different companies which I believe have the potential to deliver market-beating returns.

A FTSE 100 bargain?

British Airways owner International Consolidated Airlines Group (LSE: IAG) reported a 28.8% rise in profit after tax last year. The group’s diluted earnings rose by 25.7% to €0.88 per share, putting the stock on a trailing P/E of just 7.1.

Much of this growth was the result of IAG’s continued expansion. Available seat kilometres (a measure of capacity) rose by 9.4% to 298,431m in 2016. Reassuringly, the group’s load factor — the proportion of seats sold — remained stable, rising by 0.2% to 81.6%.

One potential problem was that pressure on ticket prices and adverse currency movements caused reported passenger revenue to fall by 2%. This was offset to some extent by lower costs, but price competition from budget airlines remains a concern.

However, IAG’s finances remain in good shape, despite pressure on ticket prices. The group’s operating margin rose from 10.1% to 11% last year, while its adjusted net debt, which includes lease costs, edged lower, falling by 4.1% to €8,159m.

Broker consensus forecasts suggest that IAG’s profits will remain flat this year, at €0.88 per share. A dividend of €0.24 per share is expected. These forecasts put IAG stock on a forecast P/E of 7.1 with a prospective yield of 3.9%.

In my view, a fair amount of bad news is already priced into the stock. If trading remains robust, I think the shares could perform well from here.

A small-cap with big potential?

Gama Aviation (LSE: GMAA) specialises in providing private jet services for corporate and government customers. Previously known as Hangar 8, Gama has grown rapidly over the last five years through a mix of acquisitions and organic growth.

The group’s sales have risen from $26.9m in 2012 to $203m in 2016. Post-tax profit has risen from $0.49m in 2012 to $16.6m last year. With such rapid growth, you might expect Gama stock to be on a sky-high P/E rating already.

That’s not the case. Gama trades on a 2017 forecast P/E of just 8.3.

One reason for this is that the group’s expansion has partly been funded by issuing a significant number of new shares. Since April 2014, Gama’s share count has risen from 9.5m to 43.9m. This means that earnings per share have not risen as fast as the group’s headline profits.

I’d normally be wary about investing in companies where shareholder dilution is a serious risk. But Gama’s return on capital employed has averaged 16.9% over the last four years, suggesting to me that the group’s acquisitions are making a fair contribution to profits.

Gama’s adjusted earnings are expected to rise by 6% to $0.32 per share in 2017 and by 11% to $0.36 per share in 2018. These forecasts put the shares on a forecast P/E of 8.3, falling to a P/E of 7.5 next year.

I’d want to do further research, but Gama looks like a potential growth buy to me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »